Open AccessEffect of switching treatment to ranibizumab or aflibercept for diabetic macular edema in patients refractory to bevacizumab
Author(s) -
Navapol Kanchanaranya,
Paiboon Bowornwattanadilok,
Onnicha Srivanich
Publication year - 2021
Publication title -
eye south east asia
Language(s) - English
Resource type - Journals
ISSN - 2586-8349
DOI - 10.36281/2021010211
Subject(s) - ranibizumab , aflibercept , bevacizumab , medicine , diabetic macular edema , refractory (planetary science) , ophthalmology , diabetic retinopathy , diabetes mellitus , chemotherapy , materials science , composite material , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom